Page 537 - Read Online

Page 8 of 10 Schulze et al. J Cancer Metastasis Treat 2020;6:42 I http://dx.doi.org/10.20517/2394-4722.2020.79

3. Hannafon BN, Ding WQ. Intercellular communication by exosome-derived microRNAs in cancer. Int J Mol Sci 2013;14:14240-69.
4. Deng F, Miller J. A review on protein markers of exosome from different bio-resources and the antibodies used for characterization. J
Histotechnol 2019;42:226-39.
5. Deng F, Magee N, Zhang Y. Decoding the role of extracellular vesicles in liver diseases. Liver Res 2017;1:147-55.
6. Bruschi M, Ravera S, Santucci L, et al. The human urinary exosome as a potential metabolic effector cargo. Expert Rev Proteomics
2015;12:425-32.
7. Keerthikumar S, Chisanga D, Ariyaratne D, et al. ExoCarta: a web-based compendium of exosomal cargo. J Mol Biol 2016;428:688-92.
8. Osaki M, Okada F. Exosomes and their role in cancer progression. Yonago Acta Med 2019;62:182-90.
9. Sun W, Luo JD, Jiang H, Duan DD. Tumor exosomes: a double-edged sword in cancer therapy. Acta Pharmacol Sin 2018;39:534-41.
10. Dilsiz N. Role of exosomes and exosomal microRNAs in cancer. Future Sci OA 2020;6:FSO465.
11. Utsugi-kobukai S, Fujimaki H, Hotta C, Nakazawa M, Minami M. MHC class I-mediated exogenous antigen presentation by exosomes
secreted from immature and mature bone marrow derived dendritic cells. Immunology Letters 2003;89:125-31.
12. Hao S, Bai O, Li F, Yuan J, Laferte S, Xiang J. Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte
responses and antitumour immunity. Immunology 2007;120:90-102.
13. Pitt JM, Charrier M, Viaud S, et al. Dendritic cell-derived exosomes as immunotherapies in the fight against cancer. J Immunol
2014;193:1006-11.
14. Admyre C, Johansson SM, Paulie S, Gabrielsson S. Direct exosome stimulation of peripheral human T cells detected by ELISPOT. Eur J
Immunol 2006;36:1772-81.
15. Fong MY, Zhou W, Liu L, et al. Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote
metastasis. Nat Cell Biol 2015;17:183-94.
16. Zhuang G, Wu X, Jiang Z, et al. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-
STAT pathway. EMBO J 2012;31:3513-23.
17. Zhou W, Fong MY, Min Y, et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell
2014;25:501-15.
18. Umezu T, Tadokoro H, Azuma K, Yoshizawa S, Ohyashiki K, Ohyashiki JH. Exosomal miR-135b shed from hypoxic multiple myeloma
cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood 2014;124:3748-57.
19. Liu MX, Liao J, Xie M, et al. miR-93-5p transferred by exosomes promotes the proliferation of esophageal cancer cells via intercellular
communication by targeting PTEN. Biomed Environ Sci 2018;31:171-85.
20. Ma T, Chen Y, Chen Y, et al. MicroRNA-132, delivered by mesenchymal stem cell-derived exosomes, promote angiogenesis in
myocardial infarction. Stem Cells Int 2018;2018:3290372.
21. Hsu YL, Hung JY, Chang WA, et al. Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability
by targeting prolyl hydroxylase and tight junction protein ZO-1. Oncogene 2017;36:4929-42.
22. Le MT, Hamar P, Guo C, et al. miR-200-containing extracellular vesicles promote breast cancer cell metastasis. J Clin Invest
2014;124:5109-28.
23. Monaco F, Gaetani S, Alessandrini F, et al. Exosomal transfer of miR-126 promotes the anti-tumour response in malignant mesothelioma:
Role of miR-126 in cancer-stroma communication. Cancer Lett 2019;463:27-36.
24. Hsu YL, Huang MS, Hung JY, et al. Bone-marrow-derived cell-released extracellular vesicle miR-92a regulates hepatic pre-metastatic
niche in lung cancer. Oncogene 2020;39:739-53.
25. Cui H, Seubert B, Stahl E, et al. Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung
adenocarcinoma cells and their exosomes. Oncogene 2015;34:3640-50.
26. Ma M, Chen S, Liu Z, et al. miRNA-221 of exosomes originating from bone marrow mesenchymal stem cells promotes oncogenic
activity in gastric cancer. Onco Targets Ther 2017;10:4161-71.
27. Bryant RJ, Pawlowski T, Catto JW, et al. Changes in circulating microRNA levels associated with prostate cancer. Br J Cancer
2012;106:768-74.
28. Ingenito F, Roscigno G, Affinito A, et al. The role of exo-miRNAs in cancer: a focus on therapeutic and diagnostic applications. Int J Mol
Sci 2019;20:4687.
29. Rana S, Malinowska K, Zöller M. Exosomal tumor microRNA modulates premetastatic organ cells. Neoplasia 2013;15:281-95.
30. Cao LQ, Yang XW, Chen YB, Zhang DW, Jiang XF, Xue P. Exosomal miR-21 regulates the TETs/PTENp1/PTEN pathway to promote
hepatocellular carcinoma growth. Mol Cancer 2019;18:148.
31. Hsu YL, Hung JY, Chang WA, et al. Hypoxic lung-cancer-derived extracellular vesicle microRNA-103a increases the oncogenic effects
of macrophages by targeting PTEN. Mol Ther 2018;26:568-81.
32. Zhang L, Zhang S, Yao J, et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth.
Nature 2015;527:100-4.
33. Liu Q, Peng F, Chen J. The role of exosomal microRNAs in the tumor microenvironment of breast cancer. Int J Mol Sci 2019;20:3884.
34. Liu X, Lu Y, Xu Y, et al. Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric
cancer. Cancer Lett 2019;459:122-34.
35. Fang T, Lv H, Lv G, et al. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis
of liver cancer. Nat Commun 2018;9:191.
36. Hashimoto K, Ochi H, Sunamura S, et al. Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic
microenvironment via targeting ARHGAP1 and FAM134A. Proc Natl Acad Sci U S A 2018;115:2204-9.